Market Overview

Morning Market Losers


Regado Biosciences (NASDAQ: RGDO) shares dipped 52.82% to $1.34 after the company reported that it had permanently terminated the Regulate-PCI clinical trial.

Qihoo 360 Technology Co (NYSE: QIHU) shares declined 7.13% to $94.50 on Q2 results. Qihoo 360 reported Q2 adjusted EPADS of $0.50 on revenue of $317.90 million.

Neovasc (NASDAQ: NVCN) shares fell 6.77% to $5.09.

Evogene (NASDAQ: EVGN) slipped 6.42% to $13.12. Evogene shares have jumped 143.83% over the past 52 weeks, while the S&P 500 index has gained 20.02% in the same period.

Greif (NYSE: GEF) shares tumbled 5.96% to $47.30 after the company cut its FY14 earnings forecast.

Optibase (NASDAQ: OBAS) shares declined 5.16% to $5.88. On Friday, Optibase posted Q2 net income of $159,000, up from $619,000 in the year-ago period.

Leju Holdings (NYSE: LEJU) dropped 5.06% to $17.48.

Posted-In: market losersNews Movers & Shakers Intraday Update Markets


Related Articles (GEF + EVGN)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

5 Basic Materials Stocks With The Lowest PEG Ratio

UPDATE: Credit Suisse Initiates Coverage On Macrocure On Potential Game Changer